Effectiveness of the Polish program for the treatment of severe allergic asthma with omalizumab: a single-center experience

被引：0
|
作者：
Izabela Kupryś-Lipińska
Paweł Majak
Joanna Molinska
Piotr Kuna
机构：
[1] Barlicki University Hospital,Department of Internal Medicine, Asthma and Allergy
[2] Medical University of Lodz,undefined
来源：
BMC Pulmonary Medicine | / 16卷
关键词：
Effectiveness; Omalizumab; Severe asthma; Severe asthma exacerbations;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Omalizumab for the treatment of severe allergic asthma in children: A tale of two
    Brannick, Sinead
    McDonald, Mary
    Greally, Peter
    Elnazir, Basil
    Ahmareen, Oneza
    CLINICAL CASE REPORTS, 2022, 10 (08):
  • [32] The eXpeRience registry: The 'real-world' effectiveness of omalizumab in allergic asthma
    Braunstahl, G. -J.
    Chen, C-W
    Maykut, R.
    Georgiou, P.
    Peachey, G.
    Bruce, J.
    RESPIRATORY MEDICINE, 2013, 107 (08) : 1141 - 1151
  • [33] Real life experience of omalizumab on selected children with severe allergic asthma
    Abusamra, Rania
    Latham, Sarah
    Chakraborty, Shrabani
    Woodman, Marc
    Bossley, Cara
    Ruiz, Gary
    Gupta, Atul
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [34] Assessment of Long-term Omalizumab Treatment in Patients with Severe Allergic Asthma Long-term Omalizumab Treatment in Severe Asthma
    Ozgur, Eylem Sercan
    Ozge, Cengiz
    Ilvan, Ahmet
    Nayci, Sibel Atis
    JOURNAL OF ASTHMA, 2013, 50 (06) : 687 - 694
  • [35] Omalizumab in the treatment of allergic asthma: experience in our immunoallergology department
    Geraldo Dias, J.
    Morais Silva, P.
    Mendes, A.
    Costa, C.
    Pedro, E.
    Pereira Barbosa, M.
    ALLERGY, 2012, 67 : 462 - 462
  • [36] THE COST EFFECTIVENESS OF OMALIZUMAB FOR THE TREATMENT OF SEVERE ALLERGIC ASHTMA IN KOREA
    Lee, J.
    Ko, S.
    VALUE IN HEALTH, 2017, 20 (09) : A647 - A647
  • [37] Omalizumab for Severe Allergic Asthma Treatment in Italy: A Cost-Effectiveness Analysis from PROXIMA Study
    Canonica, Giorgio Walter
    Colombo, Giorgio Lorenzo
    Rogliani, Paola
    Santus, Pierachille
    Pitotti, Claudia
    Di Matteo, Sergio
    Martinotti, Chiara
    Bruno, Giacomo Matteo
    RISK MANAGEMENT AND HEALTHCARE POLICY, 2020, 13 : 43 - 53
  • [38] Effectiveness of omalizumab in Greek patients with severe allergic asthma (SAA): The SMILE study
    Galanakis, Petros
    Gaga, Mina
    Psarros, Fotios
    Zervas, Eleftherios
    Mitsiki, Eirini
    Siafakas, Nikolaos
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [39] Effectiveness of 52 weeks of omalizumab therapy in patients with severe persistent allergic asthma
    Skiepko, R.
    Zietkowski, Z.
    Tomasiak, M.
    Lenczewska, D.
    Bodzenta-Lukaszyk, A.
    Skiepko, R.
    Skiepko, R.
    ALLERGY, 2010, 65 : 552 - 553
  • [40] Cost-effectiveness of omalizumab for the treatment of moderate-to-severe uncontrolled allergic asthma in the United States
    Sullivan, Patrick W.
    Li, Qianyi
    Bilir, S. Pinar
    Dang, Joseph
    Kavati, Abhishek
    Yang, Ming
    Rajput, Yamina
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (01) : 23 - 32
12345